Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
Heather J. Bax(King's College London), Sophia N. Karagiannis(King's College London), Chara Stavraka(King's College London), Sidath Katugampola(Cancer Research UK), James Spicer(King's College London), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Atousa Khiabany(King's College London), Jitesh Chauhan(King's College London), Christopher J. Corrigan(King's College London), Mano Nakamura(King's College London), Kristina M. Ilieva(King's College London), A. Winship(Guy's and St Thomas' NHS Foundation Trust), Claire Barton(University of Hertfordshire), Stephen J. Till(Guy's Hospital), Hannah J. Gould(King's College London), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Paul S. Jones(Cancer Research UK), Sara Lombardi(Federico II University Hospital), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Giulia Pellizzari(King's College London)
Cited by 52
Related Papers
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|614
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Targeting folate receptor alpha for cancer treatment
|Oncotarget|2016|447
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
|The Lancet Oncology|2019|228
Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease
|The Journal of Immunology|2018|193